Low-dose digoxin after an episode of acute heart failure

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

DIG-DICA is a randomized, controlled, open-label, single-center trial that enrolls adults with HFrEF who recently stabilized after hospitalization or urgent care for acute decompensation. Participants are randomized to usual care alone or usual care plus low-dose digoxin with dosing aimed at low therapeutic serum concentrations. The primary outcome is the proportion of patients who are "Alive and Well" at 180 days, defined by a KCCQ-12 score ≥75, and secondary outcomes include symptoms, 6-minute walk distance, NT-proBNP, renal function, and major cardiovascular events. The trial seeks to clarify whether contemporary low-dose digoxin provides meaningful clinical and quality-of-life benefits when added to guideline-directed medical therapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Male or female ≥ 18 years of age who have signed written informed consent and are willing and able to complete treatment and follow-up.
2. Recent hospitalization or emergency department visit for decompensated heart failure with reduced ejection fraction (HFrEF) (LVEF ≤ 40%).
3. Resting heart rate ≥ 60 bpm in patients without a pacemaker.
4. Distance walked on the 6-minute walk test (6MWT) ≤ 450 meters and/or less than 80% of the predicted value.
5. NT-proBNP ≥ 450 pg/mL, or ≥ 900 pg/mL in patients with atrial fibrillation, and/or echocardiographic criteria of congestion

   \-

Exclusion Criteria:

1. Resting heart rate \< 60 bpm in sinus rhythm or \< 70 bpm in atrial fibrillation.
2. Myocardial infarction, acute coronary syndrome, myocarditis, percutaneous coronary intervention, or recent implantation (within the past 3 months) of cardiac resynchronization therapy (CRT), pacemaker, or implantable cardioverter-defibrillator (ICD); cardiac surgery or stroke within the past 30 days.
3. Estimated glomerular filtration rate (eGFR) ≤ 30 mL/min/1.73 m² (based on a sample obtained within the previous month).
4. Presence of a mechanical ventricular assist device.
5. Planned implantation of a ventricular assist device or cardiac transplantation.
6. Non-cardiac comorbidities with a limited life expectancy (less than or equal to the study duration).
7. Non-cardiac conditions (neurological or orthopedic) preventing performance of the 6-minute walk test (6MWT).
8. Body mass index (BMI) ≥ 35 kg/m².
9. Amyloid, hypertrophic obstructive, or constrictive cardiomyopathy.
10. Presence of an accessory atrioventricular conduction pathway (e.g., Wolff-Parkinson-White syndrome).
11. History of symptomatic or sustained ventricular tachyarrhythmia (≥ 30 seconds).
12. Intermittent complete atrioventricular block or Mobitz type II second-degree AV block without pacemaker or ICD.
13. Severe aortic valvular disease (grade III/III) with indication for invasive treatment.
14. Complex congenital heart disease.
15. Known hypersensitivity to digoxin (including prior adverse reactions).
16. Current treatment with digoxin.
17. Participation in another clinical trial (excluding observational registries).
18. Pregnant or breastfeeding women, or women with the potential to become pregnant during the study period.

    \-

Where it's running

• Hospital General de Agudos Dr Cosme Argerich
  Buenos Aires, Buenos Aires F.D., Argentina Recruiting

Study contacts

• Study coordinator: Guillermo Ernesto Liniado, MD
• Email: guillermoliniado@yahoo.com.ar
• Phone: +5491168615900

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comprehensive clinical rule to diagnose acute heart failure in the emergency department

  A prospective study tests a combined clinical rule using patient data, a point-of-care NT-proBNP test, an 8-point lung ultrasound, and bedside echo to quickly diagnose acute heart failure in adults with new or worsening symptoms.

  Recruiting Chinese University of Hong Kong · Hong Kong and 2 other locations · NCT07754084

• Disrupted congestion in acute heart failure: can ultrasound at discharge predict readmission and death

  This study tests whether ultrasound checks of congestion at discharge can predict which patients with acute heart failure are more likely to be readmitted or die within 90 days.

  Recruiting University of Aarhus · Aarhus and 2 other locations · NCT07682298

• Pre-discharge Flu Vaccine for patients with acute heart problems

  This trial tests whether giving an influenza vaccine within 24 hours before hospital discharge helps patients who were treated for acute heart issues stay healthier this season.

  Recruiting Phase 4 Wroclaw Medical University · Wroclaw · NCT07617376

• Acute Heart Failure: How a Quantitative ECG Helps Clinicians

  This study tests whether quantitative ECG (QCG) measurements can reveal useful patterns in adults hospitalized with acute heart failure.

  Recruiting Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT07601022

• Urinary Sodium and Chloride Changes and Fluid Overload in Acute Heart Failure

  This study tests whether tracking urinary sodium and chloride during hospitalization can reflect congestion removal and predict short-term outcomes in adults with acute heart failure treated with IV diuretics.

  Recruiting Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Olot, Girona and 3 other locations · NCT07597512

• Training medical residents to use the Venous Excess Ultrasound (VExUS) score for bedside volume assessment

  This project tests whether in-person or remote training better teaches medical residents to use the VExUS ultrasound score for bedside volume checks in patients with acute heart failure.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07541768

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.